1. Home
  2. GCTS vs STRO Comparison

GCTS vs STRO Comparison

Compare GCTS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GCT Semiconductor Holding Inc.

GCTS

GCT Semiconductor Holding Inc.

N/A

Current Price

$1.11

Market Cap

185.8M

Sector

Finance

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

N/A

Current Price

$8.76

Market Cap

159.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GCTS
STRO
Founded
1998
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.8M
159.5M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
GCTS
STRO
Price
$1.11
$8.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
14
Target Price
$3.13
★ $44.69
AVG Volume (30 Days)
★ 1.7M
291.0K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$2,866,000.00
★ $38,419,000.00
Revenue This Year
$76.29
N/A
Revenue Next Year
$648.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.96
$0.72
52 Week High
$3.93
$43.85

Technical Indicators

Market Signals
Indicator
GCTS
STRO
Relative Strength Index (RSI) 38.49 35.40
Support Level $1.00 $8.11
Resistance Level $1.43 $10.77
Average True Range (ATR) 0.15 0.85
MACD 0.01 0.14
Stochastic Oscillator 23.83 17.01

Price Performance

Historical Comparison
GCTS
STRO

About GCTS GCT Semiconductor Holding Inc.

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness. Geographically, operates in South Korea and the United States, with maximum revenue from the USA.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: